Topotecan - Wikipedia
"Topotecan". Drug Information Portal. U.S. National Library of Medicine. "Topotecan hydrochloride". Drug Information Portal. U.S ... Topotecan unsilences the paternal UBE2A allele by reducing the transcription of an antisense transcript. Topotecan inhibits ... In physiological environments, topotecan is in equilibrium with its inactive carboxylate form. Topotecans active lactone form ... "FDA Approval for Topotecan Hydrochloride". National Cancer Institute. "FDA approves topotecan hydrochloride (hycamtin) in ...
Topotecan: MedlinePlus Drug Information
Topotecan: learn about side effects, dosage, special precautions, and more on MedlinePlus ... Before taking topotecan,. *tell your doctor and pharmacist if you are allergic to topotecan, any other medications, or any of ... If you become pregnant while taking topotecan, call your doctor immediately. Topotecan may harm the fetus. ... Topotecan comes as a capsule to take by mouth. It may be taken with or without food. It is usually taken once a day for 5 days ...
Topotecan (Intravenous Route) Description and Brand Names - Mayo Clinic
Topotecan injection is used to treat patients with metastatic cancer (a cancer that has already spread) of the ovaries after ... Topotecan belongs to the group of medicines called antineoplastics. It interferes with the growth of cancer cells, which are ... Some effects may occur after treatment with topotecan has been stopped. This medicine is to be given only by or under the ...
Topotecan Hycamptin | CANCERactive
Phase 2 clinical trial of intrathecal topotecan in children with refractory leptomeningeal leukemia: a Children's Oncology...
IT administration of topotecan was tolerable on this dose and schedule. The majority of adverse events were mild to moderate, ... Conclusion: IT administration of topotecan was tolerable on this dose and schedule. The majority of adverse events were mild to ... Patients and methods: Patients received age-adjusted IT topotecan (0.4 mg/dose for patients ,3 years of age) administered twice ... Phase 2 clinical trial of intrathecal topotecan in children with refractory leptomeningeal leukemia: a Childrens Oncology ...
Hycamtin (topotecan) dosing, indications, interactions, adverse effects, and more
... topotecan), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, ... topotecan intravenous TOPOTECAN - INJECTION (TOE-poe-TEE-kan) COMMON BRAND NAME(S): Hycamtin WARNING: Topotecan decreases bone ... encoded search term (topotecan (Hycamtin)) and topotecan (Hycamtin) What to Read Next on Medscape ... You should not become pregnant while using topotecan. Topotecan may harm an unborn baby. Women using this medication should ask ...
Potentiation of CD95L-Induced Apoptosis of Human Malignant Glioma Cells by Topotecan Involves Inhibition of RNA Synthesis but...
Topotecan is a novel topoisomerase I inhibitor that may have a role in the adjuvant chemotherapy of several solid tumors, ... Neither short-term nor long-term topotecan toxicity was blocked by ectopic expression ofbcl-2 or wild-type p53. Transfer of a ... High micromolar concentrations of topotecan, which are unlikely to be achieved in plasma in human patients in vivo, were ... These data suggest that topotecan needs to be administered in high concentrations, such as an intratumoral polymer, to limit ...
ZD9331 With or Without Topotecan in Treating Patients With Refractory or Recurrent Epithelial Ovarian Cancer, Fallopian Tube...
Patients receive ZD9331 as in arm I and topotecan IV over 30 minutes on days 1-5. All arms:. Treatment repeats every 21 days in ... OBJECTIVES: I. Compare the efficacy of ZD9331 with or without topotecan in patients with. refractory or recurrent ovarian ... or in Combination With Topotecan, in Patients With Ovarian Cancer Refractory or Recurrent After Failing Platinum and Paclitaxel ... or in Combination With Topotecan, in Patients With Ovarian Cancer Refractory or Recurrent After Failing Platinum and Paclitaxel ...
Three-drug intra-arterial chemotherapy using simultaneous carboplatin, topotecan and melphalan for intraocular retinoblastoma:...
Topotecan and carboplatin were chosen for a three-drug combination with melphalan because they have been used successfully as ... In the three-drug therapy, dose ranges were 2.5-7.5 mg for melphalan, 0.3-0.6 mg for topotecan, and 25-50 mg for carboplatin, ... There were a total of 61 three-drug (melphalan, carboplatin, and topotecan) infusion sessions. The mean number of three-drug ... To avoid systemic toxicity and maximise intraocular response, we have used SIAC in which melphalan is combined with topotecan ...
Pneumotox » Drug » Topotecan » I.l - Diffuse alveolar damage (DAD) (see alsoo under IIb and XVf)
R-loop formation at Snord116 mediates topotecan inhibition of Ube3a-antisense and allele-specific chromatin decondensation
... but the mechanism of topotecan action on the PWS/AS locus is unknown. Here, we demonstrate that topotecan treatment stabilizes ... R-loop formation at Snord116 mediates topotecan inhibition of Ube3a-antisense and allele-specific chromatin decondensation. ... These results demonstrate that the AS candidate drug topotecan acts predominantly through stabilizing R loops and chromatin ... Interestingly, topoisomerase inhibitors, including topotecan, were recently identified in an unbiased drug screen for compounds ...
Topotecan | Palmetto Profiles
Cyclophosphamide and topotecan as first-line salvage therapy in patients with relapsed ewing sarcoma at a single institution. J ... "Topotecan" is a descriptor in the National Library of Medicines controlled vocabulary thesaurus, MeSH (Medical Subject ... This graph shows the total number of publications written about "Topotecan" by people in this website by year, and whether " ... Camptothecin and Topotecan, Inhibitors of Transcription Factor Fli-1 and Topoisomerase, Markedly Ameliorate Lupus Nephritis in ...
Topotecan - PT Master Guide
Topotecan is indicated for the treatment of:. • metastatic carcinoma of the ovary after failure of initial or subsequent ... Topotecan in combination with cisplatin is indicated for the treatment of:. • stage IV-B, recurrent, or persistent carcinoma of ... Recommended Dosage: The recommended dose of Topotecan is 0.75 mg/m² by intravenous infusion over 30 minutes daily on days 1, 2 ... Recommended Dosage: The recommended dose of Topotecan is 1.5 mg/m² by intravenous infusion over 30 minutes daily for 5 ...
Topotecan (Hycamtin) | Davis's Drug Guide
Find information on Topotecan (Hycamtin) in Daviss Drug Guide including dosage, side effects, interactions, nursing ... "Topotecan." Daviss Drug Guide, 18th ed., F.A. Davis Company, 2023. Medicine Central, im.unboundmedicine.com/medicine/view/ ... Davis-Drug-Guide/51756/6/topotecan. Vallerand AHA, Sanoski CAC, Quiring CC. Topotecan. Daviss Drug Guide. F.A. Davis Company; ... Vallerand, A. H., Sanoski, C. A., & Quiring, C. (2023). Topotecan. In Daviss Drug Guide (18th ed.). F.A. Davis Company. https ...
Topotecan (Hycamtin) | Davis's Drug Guide
Find information on Topotecan (Hycamtin) in Daviss Drug Guide including dosage, side effects, interactions, nursing ... www.drugguide.com/ddo/view/Davis-Drug-Guide/51756/10.0/topotecan. Vallerand AHA, Sanoski CAC, Quiring CC. Topotecan. Daviss ... Vallerand, A. H., Sanoski, C. A., & Quiring, C. (2023). Topotecan. In Daviss Drug Guide (18th ed.). F.A. Davis Company. https ... TY - ELEC T1 - topotecan ID - 51756 A1 - Sanoski,Cynthia A, AU - Vallerand,April Hazard, AU - Quiring,Courtney, BT - Daviss ...
Cervical Cancer Medication: Chemotherapy Agents, Alkylating, Antineoplastics, Antimetabolite, Antineoplastics, Antimicrotubular...
Topotecan, ifosfamide, and paclitaxel also have significant activity in this setting. The combination of topotecan and ... Topotecan inhibits topoisomerase I, inhibiting DNA replication. It acts in the S phase of the cell cycle. Patients who have ... Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology ...
Anticancer ativities of topotecan-genistein combination in prostate cancer cells | fau.digital.flvc.org
... both genistein and topotecan induce cellular death in LNCaP cells, ii) topotecan-genistein combination was significantly more ... both genistein and topotecan induce cellular death in LNCaP cells, ii) topotecan-genistein combination was significantly more ... Anticancer ativities of topotecan-genistein combination in prostate cancer cells. 29 views. 6 downloads ... Anticancer ativities of topotecan-genistein combination in prostate cancer cells. Download pdf , Full Screen View ...
Topotecan Hydrochloride for Injection by Pfizer Canada ULC | PharmaChoice
Topotecan Hydrochloride for Injection by Pfizer Canada ULC - This medication may be available under multiple brand names and/or ... Each single dose vial of solution contains topotecan HCL equivalent to 4 mg of topotecan as free base in 4 mL of Sterile Water ... Topotecan is used to treat metastatic cancer of the ovary after other treatment(s) have failed. It is also used to treat small ... Anemia: Topotecan may cause low levels of red blood cells. If you experience symptoms of reduced red blood cell count (anemia) ...
Drug: Topotecan - Cancerrxgene - Genomics of Drug Sensitivity in Cancer
A Phase 2 Study of Oxaliplatin Combined With Continuous Infusion Topotecan for Patients With Previously Treated Ovarian Cancer ...
Regression of Recurrent Malignant Gliomas With Convection-Enhanced Delivery of Topotecan - Neurosurgery Blog
TagsClinical Trial, Glioblastoma, Glioma, Topotecan. Post navigation. Previous PostPrevious The V2 segment of the vertebral ... Regression of Recurrent Malignant Gliomas With Convection-Enhanced Delivery of Topotecan. Neurosurgery 69:1272-1280, 2011 DOI: ... CONCLUSION: Topotecan by convection-enhanced delivery has significant antitumor activity at concentrations that are nontoxic to ... METHODS: We performed a prospective, dose-escalation phase Ib study of the topoisomerase- I inhibitor topotecan given by ...
3.1.4.1: phosphodiesterase I - BRENDA Enzyme Database
What are some of the most common chemo drugs?
Global Topotecan Industry Research Report, Growth Trends And Competitive Analysis 2023-2029 | Market Intelligence Data
Global Topotecan Industry Research Report, Growth Trends and Competitive Analysis 2023-2029 ... 12 Topotecan Market Dynamics. 12.1 Topotecan Market Trends. 12.2 Topotecan Market Drivers. 12.3 Topotecan Market Challenges. ... Topotecan Market Trends. Table 109. Topotecan Market Drivers. Table 110. Topotecan Market Challenges. Table 111. Topotecan ... 2.5 Global Top Topotecan Countries Ranking by Market Size. 3 Topotecan Competitive by Company. 3.1 Global Topotecan Revenue by ...
Nobody out there has used Topotecan? Little response to post - SCLC GROUP - Lung Cancer Support Community
Topotecan continued to keep the disease stable so far. I had very little side effects from it. My hands would get hot and the ... I was on Topotecan after Taxol. I took 2 rounds of 6 treatments that were administered weekly. I had a 3 week break in between ... I used topotecan as part of a clinical trial, along with radiation Tx, 2 times/day for three weeks. After that, and four rounds ... Bottom line (in my opinion) is that I think Topotecan did do some good for Jim but the brain met was not able to be tackled at ...
Chemotherapy for Chronic Myelomonocytic Leukemia | American Cancer Society
Antioxidants - Pine Street Foundation
Irinotecan and Topotecan. GENISTEIN. In a cell culture study, genistein was used in combination with either irinotecan or ... When genistein and daidzein were used in combination with cisplatin and topotecan in five different ovarian cancer cell lines, ... When genistein and daidzein were used in combination with cisplatin and topotecan in five different ovarian cancer cell lines, ... In a cell culture study, genistein was used in combination with either irinotecan or topotecan. Genistein enhanced the ...
Bacillus of calmette and guerin vaccine, live (Intradermal) Advanced Patient Information - Drugs.com
Small Cell Lung Cancer Treatment (PDQ®) - NCI
Topotecan. In a randomized trial of 784 patients, the combination of oral topotecan given with cisplatin for 5 days was not ... 7% for topotecan alone) and thrombocytopenia (41% for the combination arm vs. 28% for topotecan alone).[17][Level of evidence ... Topotecan. Evidence (topotecan and other chemotherapy agents):. *A randomized comparison of second-line treatment with either ... A randomized phase III trial (CWRU-SKF-1598 [NCT00003917]) of 304 patients assessed the use of oral topotecan (2.3 mg/m2/day ...